Every study, searchable

How sensitive is evidence for recent global warming acceleration to the final years included and the model of natural variability? A registered audit uses a frozen NASA global annual temperature series. A fixed-breakpoint model estimates a warming-rate increase of 0.232 °C per decade, with a confidence interval from 0.106 to 0.358. A search over possible breakpoints gives p = 0.0271 with fitted autocorrelation, but p = 0.4078 when the recent endpoint years are excluded. Stronger assumed autocorrelation also weakens the test. These are conditional statistical results about an unadjusted series, with limited simulated power for smaller slope changes.

• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: In the frozen NASA GISTEMP annual series for 1970-2025, a fixed-2015-knot model estimates a warming-rate increase of 0.232 degrees Celsius per decade with a 95% HAC interval of 0.106 to 0.358, while the registered breakpoint-search p-value is 0.0271 through 2025, 0.4078 through 2022, and 0.1726 through 2025 when the AR(1) lag coefficient is fixed at 0.6.

Why did United States heart-disease deaths increase between 2018 and 2024? An updated analysis of final national death counts and published population estimates averages all six orders of a demographic decomposition. Known-age deaths increase by 28135. Population size contributes 25981.4 deaths, age composition 26512.2, and age-specific rates -24358.5. Demographic contributions outweigh the negative rate contribution. These are arithmetic contributions conditional on the source denominators, which change estimation methods during the period, rather than causal effects or individual mortality risks.

• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: In the bundled CDC WONDER D158 final snapshot for United States residents with known age, 2018-2024 heart-disease deaths increase by 28,135. Averaging all six orders of the population-size, age-share-vector, and age-specific-rate-vector decomposition yields contributions of +25,981.4, +26,512.2, and -24,358.5 deaths, respectively (display-rounded), so positive demographic contributions outweigh the negative rate contribution. The statement is conditional on the published population denominators and specified age bins, and is arithmetic rather than causal or an individual clinical-risk estimate.

How sensitive is a focused meta-analysis of walking and jogging for depressive symptoms? A registered audit of a fixed public extraction pools 21 direct-comparison trials and 994 participants. Post-treatment Hedges g is -0.762, with a confidence interval from -1.203 to -0.321. Every leave-one-trial-out interval excludes zero, but the usual-care-only interval and the between-study prediction interval include zero. No included trial has an overall low-risk-of-bias rating. These conditional computations support neither a uniform treatment effect nor a treatment recommendation.

• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: In the fixed Noetel et al. public extraction, the preregistered post-treatment direct comparison of walking/jogging with its specified active controls pools 21 trials and 994 participants at Hedges g=-0.762 (95% modified Hartung-Knapp confidence interval -1.203 to -0.321), all 21 single-trial-omission intervals remain below zero, but the overall prediction interval (-2.613 to 1.088) and usual-care-only confidence interval (-1.650 to 0.237) include zero and the overall-low-risk-of-bias subset has no trials, conditional on unchanged source outcomes and ratings.

Does adding a previously unextracted public registry outcome change the selected-trial evidence for ivermectin in acute outpatient COVID-19? This revised aggregate-data audit incorporates COVID-OUT's reported hospitalization/death endpoint at the common follow-up window, expanding the primary analysis to 7714 records and 98 events. The exploratory pooled risk ratio is 1.107 (95% confidence interval 0.577 to 2.123). All 550 extensions compatible with TOGETHER's separate hospitalization and death margins also include no difference. The newly retrieved appendix does not identify their overlap. A separate denominator sensitivity shows why sparse observed events cannot settle the treatment effect when outcome coverage differs. This is a correction of a targeted audit, not a comprehensive meta-analysis, proof of no effect, or treatment recommendation.

• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: Conditional on the frozen public trial tables, registry extraction and exploratory estimators, adding COVID-OUT's reported day-28 hospitalization/death endpoint yields 7,714 analysis records and pooled risk ratio 1.107 (95% modified Hartung-Knapp interval 0.577 to 2.123), all 550 compatible TOGETHER hospitalization/death union extensions include no difference, and assignments conditional on nesting COVID-OUT's endpoint denominators within its published modified-intention-to-treat cohort span trial risk ratios 0.083 to 7.766, establishing neither benefit nor equivalence.

Does maintaining normal tissue mechanics prevent cancer initiation? A focused evidence map separates the endpoints of 4 selected papers and reanalyzes an available tumor-count table. The selected contrasts occupy 4 classes, with 0 papers testing incident cancer after a mechanical intervention in humans. The table concerns already malignant cells: blocking-antibody pretreatment gives risk ratios of 0.4667 and 0.5 against its controls. These endpoints answer different questions; neither a smaller transplantation risk nor a human biomarker change establishes primary prevention. This is a bounded, exploratory source audit, not a systematic review or a new biological experiment.

• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: In a purposively selected four-paper evidence map, the coded contrasts occupy four distinct endpoint classes, only one paper starts its reprogramming program with normal primary cells, and none measures incident cancer after a mechanical intervention in humans, with all counts restricted to this selected set rather than the literature.
• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: Reanalysis of Weaver et al. (1997) Table II gives 7/16 tumor-bearing mice after blocking-antibody pretreatment of already malignant cells versus 15/16 untreated and 14/16 control-antibody mice, risk ratios 0.4667 and 0.5000, with two-sided Fisher p-values 0.005923 and 0.023333 (Holm-adjusted 0.011846 and 0.023333), while conservative simultaneous 95% risk-ratio intervals are 0.1612 to 1.1614 and 0.1625 to 1.3304 under independent-binomial sampling.

Do historical electricity schedules help when jobs arrive throughout the day and cannot wait indefinitely? We evaluated fixed seasonal profiles and recent-history profiles on public Great Britain grid records. For the primary workload, seasonal scheduling lowered mean assigned carbon intensity by 11.24% in 2024 and 12.01% in 2025 relative to immediate execution. Yet 17.61% and 15.55% of jobs received higher intensity. Recent-minus-seasonal mean differences were -0.21 and -0.07 g CO2/kWh. These are retrospective accounting results for a synthetic workload, not measured emissions avoided.

• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: Conditional on the frozen Great Britain national intensity snapshot and a uniform half-hour arrival workload, three-hour jobs allowed up to six hours of start delay have 11.24% and 12.01% lower mean assigned intensity under 2023-trained seasonal profiles than immediate execution across 17,424 and 17,472 jobs in 2024 and 2025, respectively, while 17.61% and 15.55% have higher intensity and a lagged recent-history profile changes the seasonal mean by -0.21 and -0.07 g CO2/kWh, without establishing causal emissions avoided or future workload performance.

Can a simple electricity-use schedule transfer across years? We selected seasonal three-hour windows using 2023 data and evaluated them in later Great Britain grid records. Relative to midnight use, assigned average carbon intensity was 5.78% lower in 2024 and 13.15% lower in 2025. The schedule performed worse on 137 and 111 days, respectively. A single year-round window did not improve both years. These retrospective accounting results describe the recorded grid; they do not estimate emissions avoided by changing electricity demand.

• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: In the frozen Great Britain national Carbon Intensity API actual series, three-hour seasonal UTC windows selected only from 2023 yield mean assigned-intensity reductions versus 00:00-03:00 UTC of 5.778479% across 364 complete days in 2024 and 13.150070% across 365 days in 2025, compared with -9.430428% and 2.353958% for the single 2023-selected year-round window, while the seasonal rule is worse on 137 and 111 days respectively; these are finite-period accounting comparisons and do not estimate causal emissions reductions.

Can other microbes maintain butyrate-related transcription when a leading contributor declines? A preregistered audit of public IBDMDB profiles finds that the available pathway-level species assignments are too sparse for a reliable answer. Among 375 retained paired Crohn's samples from 52 participants, the primary pathway has positive community RNA in 205 samples but named-species RNA in only 25. The specified longitudinal analysis retains 6 sustained-decline episodes from 5 people. Every retained episode has zero reported RNA from the named alternatives throughout its observation window. These zeros do not distinguish undetected or unassigned transcription from biological failure of compensation.

• Published, Reproduced, Reviewed.Published, Reproduced, Reviewed: In the audited public IBDMDB HUMAnN3 pathway tables, 375 retained paired Crohn's samples from 52 participants contain named-species PWY-5676 RNA in only 25 of 205 samples with positive community pathway RNA, and the preregistered sustained-contributor-decline analysis yields six episodes from five participants with zero reported alternative-species RNA at all three visits, preventing this operational analysis from distinguishing biological compensation failure from unresolved transcription.